BONA
5.4.2022 09:17:04 CEST | Business Wire | Press release
Bona ® , a global, sustainably-driven company that supplies products for installing, renovating, maintaining and restoring premium floors, today released the results of its 2021 Sustainability Report. The report highlights Bona’s most significant sustainability milestones for the year focused on its commitment to betterment for home, health, and humanity.
“Our commitment and responsible approach to the environment, people and society has remained steadfast for more than 100 years,” said Kerstin Lindell, Chair of the Board, Bona AB. “This past year presented some challenges, including supply chain and raw materials shortages, yet Bona stayed flexible and focused. Thanks to our fantastic team, our promise to deliver the best products and systems to our customers never wavered and we continue to identify more sustainable solutions. The ability to quickly shift, work together, and develop products and offerings despite changing market conditions has been key to our success.”
Sustainable development on the agenda
In 2021, Bona made some significant investments in its commitment to a sustainable future. The first was the introduction of an electric truck to Bona’s transportation fleet in Limburg, Germany. The electric truck will contribute to lower nitrogen dioxide levels in the city of Limburg and to global decarbonization. In Sweden, Bona invested in a geothermal system that will provide Bona’s Malmö facility with geothermal energy offsetting 20 percent of the yearly energy use at the facility. Another significant milestone last year was the purchase of 26,000-square-meters of land to build a new facility in Monroe, North Carolina, USA. The project, which will be completed in 2022, supports more efficient operations and increased internal capabilities allowing Bona US to operate in a more environmentally friendly way.
Björn Johansson Global Environmental Manager at Bona, said, “We continue to take important steps forward by increasing our use of renewable energy, smarter materials and packaging that uses less virgin plastic, and exhaustively researching new and better ingredients for our products. While we still have work to do, 2021 was a year where we made good progress.”
Highlights of the year
Bona’s core offering encourages care, maintenance, and renovation of hard flooring surfaces such as wood and resilient rather than replacing these materials thereby safeguarding the earth’s finite resources. In 2021 Bona produced finishes, stains, and sealers to cover more than 43 million square meters of wood flooring, saving a forest area equal to approximately 32 million square meters. By not cutting down the forest, the same number of trees encapsulates 28,917 tonnes of carbon dioxide (CO2), calculated as 9-ton CO by hectare and year.
Also in 2021, Bona initiated the use of 90 percent post-consumer recycled (PCR) material in its microfiber pads designed for the Bona Spray Mop and Bona Microfiber Mop. Aligning to the company’s goal to use less virgin plastic, this shift is helping divert over 217 tons of plastic waste from being incinerated or going to landfills.
In the autumn of last year, Bona received the Safer Choice Partner of the Year Award from the US Environmental Protection Agency (EPA) for its work innovating better ingredients in its floor cleaning solutions. Since becoming a Safer Choice partner in 2020, Bona has certified 13 products, six of which were certified in 2021.
Other key facts
Additional notable facts from Bona’s 2021 Sustainability report include:
- Five years ago, Bona moved its adhesive product from buckets to a tube packaging called “sausages.” In 2021 Bona reduced its environmental footprint by using sausages rather than buckets and over the past five years Bona has avoided using more than 258,000 buckets which is a carbon savings of 243,281 kg.
- An innovative ergonomic tool was launched 2021 as a new addition to the Bona FlexiSand Pro System. The Bona ErgoEdge is a machine attachment that allows flooring contractors to achieve smooth, efficient sanding in corners and edges of a floor without kneeling or bending by attaching to an existing, standing machine. This innovation saves time and offers a more ergonomic experience for the contractor all while providing a premium floor sanding experience.
- In 2021 Bona released several new products all of which were formulated with Bona’s commitment to greener chemistry including amplified formulas of its Bona Hardwood Floor and Bona Hard-Floor cleaning solutions. The formulations are water-based, biodegradable, meet the U.S. EPA product standards, and are Safer Choice Certified.
- Since 2016, Bona has collaborated with Hand in Hand, a non-governmental organization (NGO) that fights poverty with grassroots entrepreneurship, to increase the quality of life for three villages in India. With the organizations Village Upliftment Program, Bona’s partnership has helped improve living conditions for women and children through education and the creation of new jobs.
About the framework of Bona’s 2021 Sustainability Report
For the fifth year in a row, Bona reported the company's sustainability work in accordance with Swedish law and standards. The 2021 Sustainability Report aligns to the UN Sustainability goals and summarizes the sustainability information in the four areas of environment, social conditions, personnel and respect for human rights and the fight against corruption. View the full report at bona.com/sustainability
About Bona
Bona is a family-owned, sustainably driven company that supplies products for installing, renovating, maintaining and restoring premium floors. Founded in 1919, Bona was the first in the industry to offer a full system of waterborne hardwood floor finishing and floor care products. Today, Bona offers products for most premium floor surfaces including wood, tile, vinyl, resilient, rubber and laminate. Bona’s turnover is 3.1bn SEK (EUR 307 million) 2021. The head office is in Malmö, Sweden, and the company is represented globally by its 17 subsidiaries, 70 distributors, 4 production units and 600 employees. For more visit www.bona.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005107/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
